Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection

NDTV Profit

Published On

27 Dec 2022, 01:37 PM IST

Last Updated On

27 Dec 2022, 01:37 PM IST

#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive

RECOMMENDED FOR YOU

No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod

timelogo

ICMR Recommends Interventions To Meet Gap In Machines Needed For Cancer Care

timelogo

GSK Blood Cancer Drug Blenrep Fails To Win FDA Panel Support

timelogo

AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug

timelogo